Confusing product labeling and conflicting data can create challenges for patients.
Becca Resnik, RN
Advertisement
Articles by Becca Resnik, RN
Older patients’ underrepresentation in clinical trials leaves a gap in data regarding appropriate treatment.
Despite nearly one-third of reversible dementia cases being drug induced, cognitive safety is a neglected aspect of clinical trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
2
Pharmacists Can Drive Equitable Diagnostics Access, Improve Antimicrobial Resistance Stewardship
3
From Stigma to Breakthrough: Psychedelic Medicine
4
How Pharmacy and Public Health Partner to Combat Infectious Diseases
5
